FI931393A - Peptider foer anvaendning vid vaccinering och induktion av neutraliserande motkroppar mot humant immunbristvirus - Google Patents
Peptider foer anvaendning vid vaccinering och induktion av neutraliserande motkroppar mot humant immunbristvirus Download PDFInfo
- Publication number
- FI931393A FI931393A FI931393A FI931393A FI931393A FI 931393 A FI931393 A FI 931393A FI 931393 A FI931393 A FI 931393A FI 931393 A FI931393 A FI 931393A FI 931393 A FI931393 A FI 931393A
- Authority
- FI
- Finland
- Prior art keywords
- vaccinering
- neutraliserande
- motkroppar
- inuktion
- immunbristvirus
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 241000725303 Human immunodeficiency virus Species 0.000 abstract 1
- 101900082162 Human immunodeficiency virus type 1 group M subtype B Surface protein gp120 Proteins 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 239000000758 substrate Substances 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58942290A | 1990-09-27 | 1990-09-27 | |
PCT/SE1991/000641 WO1992005800A1 (en) | 1990-09-27 | 1991-09-25 | Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus |
Publications (2)
Publication Number | Publication Date |
---|---|
FI931393A0 FI931393A0 (fi) | 1993-03-26 |
FI931393A true FI931393A (fi) | 1993-03-26 |
Family
ID=24357953
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI931393A FI931393A (fi) | 1990-09-27 | 1993-03-26 | Peptider foer anvaendning vid vaccinering och induktion av neutraliserande motkroppar mot humant immunbristvirus |
Country Status (13)
Country | Link |
---|---|
US (1) | US5589175A (fi) |
EP (1) | EP0550599B1 (fi) |
JP (1) | JPH06501260A (fi) |
AT (1) | ATE238065T1 (fi) |
AU (1) | AU650911B2 (fi) |
CA (1) | CA2091263C (fi) |
DE (1) | DE69133242T2 (fi) |
ES (1) | ES2194836T3 (fi) |
FI (1) | FI931393A (fi) |
HU (1) | HU9300877D0 (fi) |
MC (1) | MC2308A1 (fi) |
OA (1) | OA09802A (fi) |
WO (1) | WO1992005800A1 (fi) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5939074A (en) * | 1986-12-30 | 1999-08-17 | The United States Of America As Represented By The Department Of Health And Human Services | Multideterminant peptide antigens |
US5346989A (en) * | 1990-08-22 | 1994-09-13 | Syntello Vaccine Development Kb | Peptides for use in induction of T cell activation against HIV-1 |
EP0594638A1 (en) * | 1991-06-03 | 1994-05-04 | Syntello Vaccine Development Ab | Peptides for use in induction of t cell activation against hiv-1 |
JPH07501516A (ja) * | 1991-08-29 | 1995-02-16 | アメリカ合衆国 | ヒトの被験者におけるhivに反応するヘルパーtリンパ球を刺激する多重決定基ペプチド抗原 |
IT1254360B (it) * | 1992-05-11 | 1995-09-14 | San Romanello Centro Fond | Epitopi immunologicamente omologhi di hla e proteine del virus hiv. |
DE4228787A1 (de) * | 1992-08-29 | 1994-03-03 | Chemotherapeutisches Forschungsinstitut Georg Speyer Haus | Neue HIV-1-Virusisolate eines Subtyps, Vakzine gegen HIV-1-Virusinfektionen dieses Subtyps und Verfahren zu ihrer Herstellung, Verwendung der HIV-1-Virusisolate |
DE69433057T2 (de) * | 1993-04-16 | 2004-06-03 | Tripep Ab | Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus |
FR2707169B1 (fr) * | 1993-06-04 | 1995-09-01 | Pasteur Institut | Antigène cellulaire CD26 impliqué dans l'infection par un rétrovirus hiv. nouveaux inhibiteurs de l'infection par HIV. * (Dipeptidyl-peptidase IV). |
FR2707170A1 (fr) * | 1993-06-04 | 1995-01-13 | Pasteur Institut | Expression des récepteurs CD4 et CD26 dans des cellules recombinantes, inhibiteurs du récepteur CD26. |
DE4405810A1 (de) | 1994-02-23 | 1995-08-24 | Behringwerke Ag | Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung |
AU2991197A (en) * | 1996-04-15 | 1997-11-07 | University Of North Carolina At Chapel Hill, The | Antigenic sequences of a sperm protein and immunocontraceptive methods |
US7048929B1 (en) * | 1997-11-10 | 2006-05-23 | Dana-Farber Cancer Institute, Inc. | Stabilized primate lentivirus envelope glycoproteins |
AU2007283731B2 (en) | 2006-08-11 | 2013-10-24 | Katholieke Universiteit Leuven | Immunogenic peptides and their use in immune disorders |
ES2545886T3 (es) | 2008-02-14 | 2015-09-16 | Life Sciences Research Partners Vzw | Inmunoterapia dirigida a patógenos intracelulares |
ES2676630T3 (es) | 2008-02-14 | 2018-07-23 | Life Sciences Research Partners Vzw | Control inmunogénico de tumores y células tumorales |
RU2615460C2 (ru) | 2010-11-25 | 2017-04-04 | Имнейт Сарл | Иммуногенные пептиды для применения в профилактике и/или лечении инфекционных заболеваний, аутоиммунных заболеваний, иммунных ответов на аллогенные факторы, аллергических заболеваний, опухолей, отторжения трансплантата и иммунных ответов против вирусных векторов. используемых для генной терапии или генной вакцинации |
GB201201511D0 (en) | 2012-01-30 | 2012-03-14 | Univ Leuven Kath | Modified epitopes for boosting CD4+ T-cell responses |
GB201309469D0 (en) | 2013-05-28 | 2013-07-10 | Imcyse Sa | Detection of CD4+ T lymphocytes |
US10729791B2 (en) | 2015-05-18 | 2020-08-04 | Imcyse Sa | Animal models for evaluating pharmaceutical compounds |
CA2995771A1 (en) | 2015-09-25 | 2017-03-30 | Imcyse Sa | Improved methods and compounds for eliminating immune responses to therapeutic agents |
AU2017252192C1 (en) | 2016-04-19 | 2023-06-08 | Imcyse Sa | Novel immunogenic CD1d binding peptides |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE64006B1 (en) * | 1984-10-18 | 1995-06-28 | Pasteur Institut | Antigens particulary envelope antigens of the virus of lymphadenopathies and of the acquired immune-deficiency syndrome and virus process for producing virus envelope antigens use of said antigens in the preparation of immunogenic compositions or for the diagnosis of the presence of antibodies against this virus |
WO1987007616A1 (en) * | 1986-06-12 | 1987-12-17 | Biogen N.V. | Peptides involved in the pathogenesis of hiv infection |
US5128319A (en) * | 1987-08-28 | 1992-07-07 | Board Of Regents, The University Of Texas System | Prophylaxis and therapy of acquired immunodeficiency syndrome |
US5019387A (en) * | 1987-09-08 | 1991-05-28 | Duke University | Production of antibodies to HIV |
WO1989005820A1 (en) * | 1987-12-21 | 1989-06-29 | Arch Development Corporation | Hiv-related antigens and antibodies |
EP0330359A3 (en) * | 1988-02-25 | 1991-06-05 | Bio-Rad Laboratories, Inc. | Composition useful in the diagnosis and treating of hiv-1 infection |
AU3557889A (en) * | 1988-04-20 | 1989-11-24 | Trustees Of The University Of Pennsylvania, The | Protective peptides derived from human immunodeficiency virus-1 gp160 |
US4943628A (en) * | 1988-06-13 | 1990-07-24 | Ortho Pharmaceutical Corporation | HIV peptide-inducted T cell stimulation |
JPH05506221A (ja) * | 1990-04-03 | 1993-09-16 | ジェネンテク,インコーポレイテッド | Hivエンベロープポリペプチド |
AP237A (en) * | 1990-05-29 | 1993-04-29 | Cedars Sinai Medical Center | Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type 1 (HIV-1) gp120 and methods of use. |
EP0594638A1 (en) * | 1991-06-03 | 1994-05-04 | Syntello Vaccine Development Ab | Peptides for use in induction of t cell activation against hiv-1 |
-
1991
- 1991-09-25 EP EP91917502A patent/EP0550599B1/en not_active Expired - Lifetime
- 1991-09-25 WO PCT/SE1991/000641 patent/WO1992005800A1/en active IP Right Grant
- 1991-09-25 CA CA002091263A patent/CA2091263C/en not_active Expired - Fee Related
- 1991-09-25 AU AU86435/91A patent/AU650911B2/en not_active Ceased
- 1991-09-25 DE DE69133242T patent/DE69133242T2/de not_active Expired - Fee Related
- 1991-09-25 ES ES91917502T patent/ES2194836T3/es not_active Expired - Lifetime
- 1991-09-25 HU HU93877A patent/HU9300877D0/hu unknown
- 1991-09-25 AT AT91917502T patent/ATE238065T1/de not_active IP Right Cessation
- 1991-09-25 JP JP3516126A patent/JPH06501260A/ja active Pending
- 1991-09-27 MC MC912308D patent/MC2308A1/xx unknown
-
1993
- 1993-03-23 OA OA60353A patent/OA09802A/en unknown
- 1993-03-26 FI FI931393A patent/FI931393A/fi not_active Application Discontinuation
-
1995
- 1995-03-27 US US08/410,384 patent/US5589175A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
FI931393A0 (fi) | 1993-03-26 |
EP0550599A1 (en) | 1993-07-14 |
OA09802A (en) | 1994-04-15 |
ATE238065T1 (de) | 2003-05-15 |
WO1992005800A1 (en) | 1992-04-16 |
US5589175A (en) | 1996-12-31 |
AU650911B2 (en) | 1994-07-07 |
CA2091263A1 (en) | 1992-03-28 |
CA2091263C (en) | 2003-05-06 |
EP0550599B1 (en) | 2003-04-23 |
ES2194836T3 (es) | 2003-12-01 |
HU9300877D0 (en) | 1993-06-28 |
AU8643591A (en) | 1992-04-28 |
DE69133242D1 (de) | 2003-05-28 |
MC2308A1 (fr) | 1993-09-27 |
DE69133242T2 (de) | 2004-02-19 |
JPH06501260A (ja) | 1994-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI931393A0 (fi) | Peptider foer anvaendning vid vaccinering och induktion av neutraliserande motkroppar mot humant immunbristvirus | |
FI932561A (fi) | Proteiner med foeraendrade epitoper och foerfaranden foer deras framstaellning | |
FI941199A0 (fi) | Immunoreaktiiviset hepatiitti-C-viruksen polypeptidikoostumukset | |
DK0891982T3 (da) | HIV-peptider | |
DK0853633T3 (da) | Humant monoklonalt antistof imod hepatitis B virus overfladeantigen (HBVsAg) | |
ES2013328A6 (es) | Un metodo para detectar anticuerpos contra antigenos hiv-1. | |
DE3852054D1 (de) | Monoklonale Antikörper gegen Glycolipid-Antigene und ihre Verwendung. | |
WO1991004273A3 (en) | Novel peptides associated with the cd4 binding region of gp120 and their methods of use | |
DE3855134T2 (de) | Monoklonale menschliche antikörper gegen hiv-i | |
ATE67313T1 (de) | Nachweis von menschlichem cytomegalovirusspezifischem igm. | |
DE69330352D1 (de) | Mittel und methoden zur verbesserung der keratinocytenadhäsion an der haut | |
ATE119203T1 (de) | Monoklonale antikörper von mäusen gegen das gp41 protein von menschlichem immunmangelsyndrom- virus. | |
ATE134649T1 (de) | Arzneimittel und verfahren zur behandlung von erworbenem immundefizienzsyndrom (aids) und aids- verwandtem komplex unter verwendung von karbohydratspezifischen antikörpern | |
KR900011477A (ko) | 항-트립타아제 항체 및 이것을 사용한 후천성 면역결핍증 치료용 조성물 | |
RU94046321A (ru) | Моноклональные муриновые антиидиотипические антитела, способ их получения и их применение, способы иммунизации и фармацевтический состав на их основе | |
HUP0003511A2 (hu) | Hepatitisz-B-vírus polipeptidek | |
RU93004854A (ru) | Пептиды для вакцинации и индукции нейтрализующих антител против вируса иммунодефицита человека | |
DE69010897D1 (de) | Verwendung von monoklonalen Antikörpern gegen B2-Mikroglobulin. | |
BG51731A1 (en) | Hybridome cellular line mus musculus balb/c, secreting monoclonal antibody against antigenic deternimant, common for the strains hantaan and finnish of the virus of haemorrhagic fever with nephritic syndrome |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed |